Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs ...
Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.
Aurobindo Pharma has also been granted competitive generic therapy designation for these Cephalexin Tablets, qualifying the ...
On Tuesday, Nifty traded within a 160-point range but ended slightly below the flat line, marking its third consecutive day ...
Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...
Adani Enterprises has consolidated its two subsidiaries, Adani Infrastructure and Mundra Solar Technology, into Adani New ...
Aurobindo Pharma gains FDA approval for Cephalexin Tablets, bioequivalent to Keflet, with CGT designation and shared exclusivity.
In today's trade, shares of Maruti Suzuki, Dabur, Marico, Aurobindo Pharma, Angel One among others will be in focus due to ...
The Hyderabad-based pharmaceutical manufacturing company said the observations are of procedural in nature and will be ...
Ruchit Jain of 5paisa has recommended two stocks today - Amara Raja Energy & Mobility Ltd, and Aurobindo Pharma Futures.
ThePrint on MSN3d
What is ‘electoral bonds extortion’ complaint that led to FIR against Sitharaman, BJP office-bearersScope of complaint not limited to Vedanta or Aurobindo Pharma, will now get FIRs registered in other cases of ‘extortion’ of ...
Aurobindo Pharma slipped 2.60% to Rs 1,470.45 after US Food and Drug Administration (USFDA) issued 10 observations to the company's wholly owned subsidiary, Apitoria Pharma's API manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback